Cohort of patients treated for acne at Nantes University Hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to gather data from patients visiting the specialized acne consultation at Nantes University Hospital for the first time. It will assess various factors influencing the severity of acne, including both endogenous and environmental elements, while also evaluating the quality of life and psychological impact on patients. The study will include patients who consent to participate and will follow them over time to determine therapeutic responses and other relevant outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with acne
* Patient (or parents/guardians for minors) who are not opposed to participating in the cohort.
* Subjects affiliated to an appropriate health insurance

Exclusion Criteria:

* Dermatosis of the face other than acne
* Refusal to participate by the minor or parent/guardian
* Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)

Where it's running

• CHU de Nantes
  Nantes, France Recruiting

Study contacts

• Principal investigator: Brigitte DRENO, PU-PH — Nantes University Hospital
• Study coordinator: Brigitte DRENO
• Email: brigitte.dreno@wanadoo.fr
• Phone: 0240083137

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adapalene/Clindamycin Gel in Vietnamese Acne Patients

  This study tests how safe and tolerable and how well Klenzit-C works when used in routine care by Vietnamese patients aged 12 and up with mild to moderate acne.

  Recruiting at 2 sites Phase 4 Ir Innovate Research Private Limited · Hanoi and 2 other locations · NCT07918001

• Skincare regimen for mild to moderate acne in people with sensitive skin

  A 4-week test will check if a skincare regimen helps with mild to moderate acne in adults with sensitive skin.

  Recruiting USMARI Research & Innovation Centre · Petaling Jaya, Selangor · NCT07749469

• Engineered Lactobacillus reuteri cream with zinc sulfate–tannic acid MPN coating for acne

  This trial will test whether a topical cream containing engineered Lactobacillus reuteri with a zinc sulfate–tannic acid coating can reduce inflammatory acne in adults aged 18–33.

  Recruiting Phase 2 Shenzhen People's Hospital · Shenzhen, Guangdong · NCT07366229

• Probiotic drink for skin inflammation during the menopausal transition

  This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.

  Recruiting King's College London · London, London · NCT07341087

• Acne mRNA vaccine for adults with mild facial acne

  This trial will test two injections of an acne mRNA vaccine versus placebo in adults 18–45 with mild facial acne to see if it's safe, triggers an immune response, and improves acne.

  Recruiting at 4 sites Phase 1/2 Sanofi · Encino, California and 3 other locations · NCT07013747

• Evaluating the safety and effects of TVB-3567 in healthy individuals and those with acne

  This study is testing a new drug called TVB-3567 to see how safe it is and how it works in healthy people and those with acne.

  Recruiting at 3 sites Phase 1 Sagimet Biosciences Inc. · Tempe, Arizona and 5 other locations · NCT06989840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.